These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10146884)
1. Sequential antimicrobial therapy: a realistic approach to cost containment? Guay DR Pharmacoeconomics; 1993 May; 3(5):341-4. PubMed ID: 10146884 [No Abstract] [Full Text] [Related]
2. Sequential antimicrobial therapy--the role of quinolones. Nathwani D; Tillotson G; Davey P J Antimicrob Chemother; 1997 Apr; 39(4):441-6. PubMed ID: 9145815 [No Abstract] [Full Text] [Related]
3. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach]. Turc J; Eve O; Tran Van D; Wey PF; Martinez JY Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451 [No Abstract] [Full Text] [Related]
4. Intravenous to oral (iv:po) anti-infective conversion therapy. Wetzstein GA Cancer Control; 2000; 7(2):170-6. PubMed ID: 10783821 [No Abstract] [Full Text] [Related]
5. Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care health facility. Zamin MT; Pitre MM; Conly JM Ann Pharmacother; 1997 May; 31(5):564-70. PubMed ID: 9161649 [TBL] [Abstract][Full Text] [Related]
6. A pharmacist-initiated program of intravenous to oral antibiotic conversion. Przybylski KG; Rybak MJ; Martin PR; Weingarten CM; Zaran FK; Stevenson JG; Levine DP Pharmacotherapy; 1997; 17(2):271-6. PubMed ID: 9085318 [TBL] [Abstract][Full Text] [Related]
7. Development of a patient-focused, interdisciplinary antimicrobial management program involving staff pharmacists. Lacy MK; Swartz MA; Eidem LA; Bond JA Am J Health Syst Pharm; 1997 Aug; 54(16):1837-41. PubMed ID: 9269521 [No Abstract] [Full Text] [Related]
9. [Economic considerations on the use of the new fluoroquinolones in the hospital setting]. Maggiolo F; Pellegata G; Marchetti G; Suter F G Ital Chemioter; 1989; 36(1-3):101-4. PubMed ID: 2488906 [TBL] [Abstract][Full Text] [Related]
10. Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis. Amodio-Groton M; Madu A; Madu CN; Briceland LL; Seligman M; McMaster P; Miller MH Ann Pharmacother; 1996 Jun; 30(6):596-602. PubMed ID: 8792944 [TBL] [Abstract][Full Text] [Related]
11. Conference tackles overprescribing of antimicrobials. Traynor K Am J Health Syst Pharm; 2004 Aug; 61(16):1643, 1647-8. PubMed ID: 15540473 [No Abstract] [Full Text] [Related]
12. [Study of the cost-effectiveness of sequential antibiotic (ciprofloxacin) therapy]. Ludwig E; Kovács G; Nagy G; Székely E Orv Hetil; 1997 Nov; 138(48):3043-7. PubMed ID: 9441266 [TBL] [Abstract][Full Text] [Related]
13. Implementing a program for switching from i.v. to oral antimicrobial therapy. Wong-Beringer A; Nguyen KH; Razeghi J Am J Health Syst Pharm; 2001 Jun; 58(12):1146-9. PubMed ID: 11449860 [TBL] [Abstract][Full Text] [Related]
14. Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents? Vogel F Drugs; 2002; 62(2):309-17. PubMed ID: 11817975 [TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on the pharmacoeconomic expediency of the use of fluoroquinolones]. Mokhov OI Antibiot Khimioter; 1999; 44(7):7-15. PubMed ID: 10494377 [No Abstract] [Full Text] [Related]
16. General principles of antimicrobial therapy. Thompson RL; Wright AJ Mayo Clin Proc; 1998 Oct; 73(10):995-1006. PubMed ID: 9787752 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance: cost and containment. Coast J; Smith RD Expert Rev Anti Infect Ther; 2003 Aug; 1(2):241-51. PubMed ID: 15482119 [TBL] [Abstract][Full Text] [Related]
18. [Home intravenous antimicrobial therapy]. González Ramallo VJ; Bouza Santiago E Med Clin (Barc); 2008 Sep; 131(8):295-7. PubMed ID: 18803924 [No Abstract] [Full Text] [Related]